Biliary Tract Cancer Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: Biliary tract cancer / Cancers, Biliary Tract / Malignant neoplasm of biliary tract, unspecified / Malignant tumor of biliary tract / Malignant neoplasm of biliary tract, part unspecified

IndicationStatusPhase
DBCOND0030617 (Biliary Tract Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03639935Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum TherapyTreatment